HealthPartners Neuroscience Center
Saint Paul, Minnesota, 55130, United States
NCT Number: NCT04062227
Mindfulness based stress reduction (MBSR) refers to a particular type of attention focused on the present moment, non-judgmental awareness, and acceptance of that experience with openness and curiosity. Mindfulness training was designed to enhance the range and use of coping skills, decrease levels of stress, improve mood, and reduce tendencies to react in maladaptive ways 1-3. Investigators are evaluating a new program, called the Mindfulness Based Dementia-Care (MBDC) in caregivers (CG) for dementia, which combines the traditional approaches with education. The overall objective of this study is to evaluate the program and explore the potential benefits of the Mindfulness Based Dementia-Care (MBDC) program. Investigators are conducting a prospective, pre-post, observational study with members participating in the MBDC program.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Saint Paul, Minnesota, 55130, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline, 8 weeks
The Perceived Stress Scale (PSS) scores on a total score. The range of the PSS is 0-40 points. A lower score is indicative of lower stress.
Time frame: baseline, 8 weeks
The CES-D scores on a total score. The range of the CES-D is 0-60 points. A higher score is indicative of the presence of more depression symptoms.
Time frame: baseline, 8 weeks
The SCS scores on a mean score. The range of the SCS is 1-5 points. A higher score is indicative higher self-compassion.
Time frame: baseline, 8 weeks
The Resilience Scale scores on a total score. The range of The Resilience Scale is 14-98 points. A higher score is indicative of higher resilience.
Time frame: baseline, 8 weeks
The Zarit Caregiver Burden Scale scores on a total score. The range of the Zarit range is 0-88 points. A higher score is indicative of the presence of a higher level of caregiver burden.
Time frame: baseline, 8 weeks
The Brief COPE scores on fourteen subscale scores. Sub-scores are totaled to give a total range [14-112]. Higher scores indicate increased utilization of coping strategy.
Time frame: baseline, 5 months
The Perceived Stress Scale (PSS) scores on a total score. The range of the PSS is 0-40 points. A lower score is indicative of lower stress.
Time frame: baseline, 5 months
The CES-D scores on a total score. The range of the CES-D is 0-60 points. A higher score is indicative of the presence of more depression symptoms.
Time frame: baseline, 5 months
The Resilience Scale scores on a total score. The range of The Resilience Scale is 14-98 points. A higher score is indicative of higher resilience.
Time frame: baseline, 5 months
The Zarit Caregiver Burden Scale scores on a total score. The range of the Zarit range is 0-88 points. A higher score is indicative of the presence of a higher level of caregiver burden.
Time frame: baseline, 5 months
The Brief COPE scores on fourteen subscale scores. Sub-scores are totaled to give a total range [14-112]. Higher scores indicate increased utilization of coping strategy.
HealthPartners Institute
Other
MBDC-The Mindfulness Based Dementia-Care Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04627662
Alzheimer Disease, Behavior
Portland, Oregon, United States
View Trial DetailsNCT05465109
Behavior, Behavioral Symptoms
Minneapolis, Minnesota, United States
View Trial DetailsNCT05012410
Alzheimer Disease, Arterial Occlusive Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05150990
Alzheimer Disease, Behavior
Calabasas, California, United States
View Trial Details